RIA
ABMD

Realta Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Realta Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-605
Closed -$200K – 449
2022
Q1 		$200K Hold
605
– – 0.04% 402
2021
Q4 		$217K Buy
+605
New +$204K 0.05% 383
2020
Q1 		– Sell
-50
Closed -$10K – 1518
2019
Q4 		$10K Sell
50
-250
-83% -$46.3K ﹤0.01% 1151
2019
Q3 		$53K Buy
+300
New +$64.8K 0.01% 661
2019
Q2 		– Sell
-600
Closed -$171K – 1840
2019
Q1 		$171K Buy
+600
New +$199K 0.08% 306

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Realta Investment Advisors's ABMD Position: Q2 2022 in Review

Realta Investment Advisors sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 605 shares — an estimated $200K sold.

Realta Investment Advisors first reported a position in ABMD in Q1 2019 and held it in 5 quarters. The position peaked at $217K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Realta Investment Advisors reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Realta Investment Advisors sold 605 Abiomed Inc shares in Q2 2022, an estimated $200K.
  • Realta Investment Advisors first reported a position in Abiomed Inc in Q1 2019 and held it in 5 quarters.
  • Realta Investment Advisors's Abiomed Inc position peaked at $217K in Q4 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Realta Investment Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.